[1] LI Z L, WU H, ZHU J Q,et al. Novel strategy for optimized nanocatalytic tumor therapy: from an updated view. Small Science, 2022, 2(7): 2200024. [2] YANG B W, CHEN Y, SHI J L.Nanocatalytic medicine.Advanced Materials, 2019, 31(39): e1901778. [3] WU Aijun, ZHU Min, ZHU Yufang.Copper-incorporated Calcium Silicate Nanorods Composite Hydrogels for Tumor Therapy and Skin Wound Healing. Journal of Inorganic Materials, 2022, 37(11): 1203. [4] ZHU L P, DAI Y L, GAO L Z,et al. Tumor microenvironment-modulated nanozymes for NIR-II-triggered hyperthermia-enhanced photo-nanocatalytic therapy via disrupting ROS homeostasis. International Journal of Nanomedicine, 2021, 16: 4559. [5] TANG Z M, ZHAO P R, WANG H,et al. Biomedicine meets Fenton chemistry. Chemical Reviews, 2021, 121: 1981. [6] BIAN Y L, LIU B, LIANG S,et al. Cu-based MOFs decorated dendritic mesoporous silica as tumor microenvironment responsive nanoreactor for enhanced tumor multimodal therapy. Chemical Engineering Journal, 2022, 435(2): 135046. [7] ZHANG Wenjun, ZHAO Xueying, LÜ Jiangwei, QU Youpeng.Progresses on Hollow Periodic Mesoporous Organosilicas: Preparation and Application in Tumor Therapy.Journal of Inorganic Materials, 2022, 37(11): 1192-1202. [8] LIU Y, WANG Y H, SONG S Y,et al. Cancer therapeutic strategies based on metal ions. Chemical Science, 2021, 12(37): 12234. [9] SUN Q Q, WANG Z, LIU B,et al. Recent advances on endogenous/exogenous stimuli-triggered nanoplatforms for enhanced chemodynamic therapy. Coordination Chemistry Reviews, 2022, 451: 214267. [10] WANG Z, LIU B, SUN Q Q,et al. Fusiform-like copper(II) based metal-organic framework through relief hypoxia and GSH-depletion co-enhanced starvation and chemodynamic synergetic cancer therapy. ACS applied materials & interfaces, 2020, 12(15): 17254. [11] SHENOY N, CREAGAN E, WITZIG T,et al. Ascorbic acid in cancer treatment: let the phoenix fly. Cancer Cell, 2018, 34(5): 700. [12] DOSKEY C M, BURANASUDJA V, WAGNER B A,et al. Tumor cells have decreased ability to metabolize H2O2: Implications for pharmacological ascorbate in cancer therapy. Redox Biology, 2016, 10: 274. [13] YANG B W, SHI J L.Ascorbate tumor chemotherapy by an iron-engineered nanomedicine catalyzed tumor-specific pro-oxidation.Journal of the American Chemical Society, 2020, 142(52): 21775. [14] AI Y J, SUN H, GAO Z X,et al. Dual enzyme mimics based on metal-ligand cross-linking strategy for accelerating ascorbate oxidation and enhancing Tumor Therapy. Advanced Functional Materials, 2021, 31(40): 2103581. [15] WU M Q, DING Y M, LI L L.Recent progress in the augmentation of reactive species with nanoplatforms for cancer therapy.Nanoscale, 2019, 11: 19658. [16] FANG C, DENG Z, CAO G,et al. Co-ferrocene MOF/Glucose oxidase as cascade nanozyme for effective tumor therapy. Advanced Functional Materials, 2020, 30: 1910058. [17] ZHANG C Y, YAN L, WANG X,et al. Tumor microenvironment-responsive Cu2(OH)PO4 nanocrystals for selective and controllable radiosentization via the X-ray-triggered Fenton-like reaction. Nano Letters, 2019, 19(3): 1749. [18] DONG S M, DONG Y S, JIA T,et al. GSH depleted nanozymes with hyperthermia-enhanced dual enzyme-mimic activities for tumor nanocatalytic therapy. Advanced Materials, 2020, 32(42): e2002439. [19] CHEN T, ZENG W W, LIU Y Q,et al. Cu-doped polypyrrole with multi-catalytic activities for sono-enhanced nanocatalytic tumor therapy. Small, 2022, 18(29): 2270152. [20] NIU Jiaxue, SUN Si, LIU Pengfei, ZHANG Xiaodong, MU Xiaoyu.Copper-based Nanozymes: Properties and Applications in Biomedicine.Journal of Inorganic Materials, 2023, 38(5): 489-502. [21] XU W J, WANG Y P, HOU G H,et al. Tumor microenvironment responsive hollow nanoplatform for triple amplification of oxidative stress to enhance cuproptosis-based synergistic cancer therapy. Advanced healthcare materials, 2023, doi.org/10.1002/adhm.202202949. [22] XU W J, QIAN J M, HOU G H,et al. A hollow amorphous bimetal organic framework for synergistic cuproptosis/ferroptosis/Apoptosis anticancer therapy via disrupting intracellular redox homeostasis and Copper/Iron metabolisms. Advanced Functional Materials, 2022, 32(40): 1. [23] SHAO L J, HU T S, FAN X Y,et al. Intelligent nanoplatform with multitherapeutic modalities for synergistic cancer therapy. ACS Applied Materials & Interfaces, 2022, 14(11): 13122. [24] MIAO Y L, QIU Y D, YANG W J,et al. Charge reversible and bio-degradable nanocarriers showing dual pH-/reduction-sensitive disinte-gration for rapid site-specific drug delivery. Colloids and Surfaces B: Biointerfaces, 2018, 169: 313. [25] TESTA U, PELOSI E, CASTELLI G.New promising developments for potential therapeutic applications of high-dose ascorbate as an anticancer drug.Hematology/Oncology and Stem Cell Therapy, 2021, 14(3): 179. [26] LEVINE M, VIOLET P C.Data Triumph at C.Cancer cell, 2017, 31(4): 467. [27] WANG Yuwei, CHEN Jiajie, TIAN Zhengfang, ZHU Min, ZHU Yufang.Potassium Ferrate-loaded Porphyrin-based (VI) Metal-organic Frameworks for Combined Photodymanic and Chemodynamic Tumor Therapy.Journal of Inorganic Materials, 2021, 36(12): 1305. [28] WU W C, YU L D, JIANG Q Z, et al. Enhanced tumor-specific disulfiram chemotherapy by in situ Cu2+ chelation-initiated nontoxicity-to-toxicity transition. Journal Of The American Chemical Society, 2019, 141(29): 11531. [29] CHENG L C, MA H, SHAO M K, et al. Synthesis of folate?chitosan nanoparticles loaded with ligustrazine to target folate receptor positive cancer cells. Molecular medicine reports, 2017, 16(2): 1101. [30] HONG J Y, SUN Z H, LI Y J,et al. Folate-modified annonaceous acetogenins nanosuspensions and their improved antitumor efficacy. International Journal Of Nanomedicine, 2017, 12(1): 5053. [31] ZHANG L Z, YANG A J, RUAN C P,et al. Copper-nitrogen-coordinated carbon dots: transformable phototheranostics from precise PTT/PDT to post-treatment imaging-guided PDT for residual tumor cells. ACS Applied Materials & Interfaces, 2023, 15(2): 3253. |